A prospective, multicenter phase I/II study of induction chemotherapy with docetaxel, cisplatin and fluorouracil (DCF) followed by chemoradiotherapy in patients with unresectable locally advanced esophageal carcinoma.

导出 OA

翻译打印收藏纠错

第一作者： Hironaga,Satake

第一单位： Department of GI Oncology, National Cancer Center Hospital East, Kashiwa, Japan.

作者： Hironaga,Satake ^[1] ; Makoto,Tahara ^[2] ; Satoshi,Mochizuki ^[3] ; Ken,Kato ^[4] ; Hiroki,Hara ^[5] ; Tomoya,Yokota ^[6] ; Naomi,Kiyota ^[7] ; Takayuki,Kii ^[8] ; Keisho,Chin ^[9] ; Sadamoto,Zenda ^[10] ; Takashi,Kojima ^[11] ; Hideaki,Bando ^[1] ; Tomoko,Yamazaki ^[1] ; Satoru,Iwasa ^[1] ; Yoshitaka,Honma ^[5] ; Satoru,Hamauchi ^[5] ; Takahiro,Tsushima ^[7] ; Atsushi,Ohtsu ^[7]

作者单位： Department of GI Oncology, National Cancer Center Hospital East, Kashiwa, Japan. ^[1] Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan. ^[2] Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, 277-8577, Japan. matahara@east.ncc.go.jp. ^[3] Gastroenterology Division, Tokatsu-Tsujinaka Hospital, Abiko, Japan. ^[4] Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan. ^[5] Department of Gastroenterology, Saitama Cancer Center, Saitama, Japan. ^[6] Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan. ^[7] Department of Oncology, Kobe University Hospital, Kobe, Japan. ^[8] Department of Cancer Chemotherapy Center, Osaka Medical College, Osaka, Japan. ^[9] Department of Gastroenterology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan. ^[10] Division of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Japan. ^[11]

关键词 Chemoradiotherapy DCF Esophageal carcinoma Induction chemotherapy Squamous cell carcinoma